228 related articles for article (PubMed ID: 23575685)
1. Structure of ERK2 bound to PEA-15 reveals a mechanism for rapid release of activated MAPK.
Mace PD; Wallez Y; Egger MF; Dobaczewska MK; Robinson H; Pasquale EB; Riedl SJ
Nat Commun; 2013; 4():1681. PubMed ID: 23575685
[TBL] [Abstract][Full Text] [Related]
2. The anti-apoptotic protein PEA-15 is a tight binding inhibitor of ERK1 and ERK2, which blocks docking interactions at the D-recruitment site.
Callaway K; Abramczyk O; Martin L; Dalby KN
Biochemistry; 2007 Aug; 46(32):9187-98. PubMed ID: 17658892
[TBL] [Abstract][Full Text] [Related]
3. Structural Studies of ERK2 Protein Complexes.
Weijman JF; Riedl SJ; Mace PD
Methods Mol Biol; 2017; 1487():53-63. PubMed ID: 27924558
[TBL] [Abstract][Full Text] [Related]
4. PEA-15 binding to ERK1/2 MAPKs is required for its modulation of integrin activation.
Chou FL; Hill JM; Hsieh JC; Pouyssegur J; Brunet A; Glading A; Uberall F; Ramos JW; Werner MH; Ginsberg MH
J Biol Chem; 2003 Dec; 278(52):52587-97. PubMed ID: 14506247
[TBL] [Abstract][Full Text] [Related]
5. Profound conformational changes of PED/PEA-15 in ERK2 complex revealed by NMR backbone dynamics.
Twomey EC; Cordasco DF; Wei Y
Biochim Biophys Acta; 2012 Dec; 1824(12):1382-93. PubMed ID: 22820249
[TBL] [Abstract][Full Text] [Related]
6. PEA-15 C-Terminal Tail Allosterically Modulates Death-Effector Domain Conformation and Facilitates Protein-Protein Interactions.
Crespo-Flores SL; Cabezas A; Hassan S; Wei Y
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284641
[TBL] [Abstract][Full Text] [Related]
7. Potential involvement of extracellular signal-regulated kinase 1 and 2 in encystation of a primitive eukaryote, Giardia lamblia. Stage-specific activation and intracellular localization.
Ellis JG; Davila M; Chakrabarti R
J Biol Chem; 2003 Jan; 278(3):1936-45. PubMed ID: 12397063
[TBL] [Abstract][Full Text] [Related]
8. Phosphoprotein enriched in astrocytes 15 kDa (PEA-15) reprograms growth factor signaling by inhibiting threonine phosphorylation of fibroblast receptor substrate 2alpha.
Haling JR; Wang F; Ginsberg MH
Mol Biol Cell; 2010 Feb; 21(4):664-73. PubMed ID: 20032303
[TBL] [Abstract][Full Text] [Related]
9. The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions.
Whitehurst AW; Robinson FL; Moore MS; Cobb MH
J Biol Chem; 2004 Mar; 279(13):12840-7. PubMed ID: 14707138
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2.
Eblen ST; Catling AD; Assanah MC; Weber MJ
Mol Cell Biol; 2001 Jan; 21(1):249-59. PubMed ID: 11113199
[TBL] [Abstract][Full Text] [Related]
11. Quantifying ERK2-protein interactions by fluorescence anisotropy: PEA-15 inhibits ERK2 by blocking the binding of DEJL domains.
Callaway K; Rainey MA; Dalby KN
Biochim Biophys Acta; 2005 Dec; 1754(1-2):316-23. PubMed ID: 16324895
[TBL] [Abstract][Full Text] [Related]
12. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
Bardwell AJ; Abdollahi M; Bardwell L
Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
[TBL] [Abstract][Full Text] [Related]
13. Recognition of ERK MAP kinase by PEA-15 reveals a common docking site within the death domain and death effector domain.
Hill JM; Vaidyanathan H; Ramos JW; Ginsberg MH; Werner MH
EMBO J; 2002 Dec; 21(23):6494-504. PubMed ID: 12456656
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation.
Krueger J; Chou FL; Glading A; Schaefer E; Ginsberg MH
Mol Biol Cell; 2005 Aug; 16(8):3552-61. PubMed ID: 15917297
[TBL] [Abstract][Full Text] [Related]
15. PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2.
Glading A; Koziol JA; Krueger J; Ginsberg MH
Cancer Res; 2007 Feb; 67(4):1536-44. PubMed ID: 17308092
[TBL] [Abstract][Full Text] [Related]
16. Activated ERK2 is a monomer in vitro with or without divalent cations and when complexed to the cytoplasmic scaffold PEA-15.
Kaoud TS; Devkota AK; Harris R; Rana MS; Abramczyk O; Warthaka M; Lee S; Girvin ME; Riggs AF; Dalby KN
Biochemistry; 2011 May; 50(21):4568-78. PubMed ID: 21506533
[TBL] [Abstract][Full Text] [Related]
17. A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates.
Zhang J; Zhou B; Zheng CF; Zhang ZY
J Biol Chem; 2003 Aug; 278(32):29901-12. PubMed ID: 12754209
[TBL] [Abstract][Full Text] [Related]
18. Engineering and cytosolic delivery of a native regulatory protein and its variants for modulation of ERK2 signaling pathway.
Ryou JH; Sohn YK; Kim DG; Kyeong HH; Kim HS
Biotechnol Bioeng; 2018 Apr; 115(4):839-849. PubMed ID: 29240226
[TBL] [Abstract][Full Text] [Related]
19. The WW domain of the scaffolding protein IQGAP1 is neither necessary nor sufficient for binding to the MAPKs ERK1 and ERK2.
Bardwell AJ; Lagunes L; Zebarjedi R; Bardwell L
J Biol Chem; 2017 May; 292(21):8750-8761. PubMed ID: 28396345
[TBL] [Abstract][Full Text] [Related]
20. PEA-15 engages in allosteric interactions using a common scaffold in a phosphorylation-dependent manner.
Ikedife J; He J; Wei Y
Sci Rep; 2022 Jan; 12(1):116. PubMed ID: 34997083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
